SCHEMBL21385245

SCHEMBL21385245

O=C(Nc1ccc(C(F)(F)F)cc1Cl)c1cccc(Cl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.62
CYP1A2 P05177 2/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C19 P33261 2/20 0.58
CYP3A4 P08684 1/20 0.58
MAPT P10636 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
NPSR1 Q6W5P4 2/20 0.55
KCNMA1 Q12791 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PPARG P37231 1/20 0.54
PPARD Q03181 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
RAB9A P51151 1/20 0.53
GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27532598 0.82 MEN1 (0.59) RXFP1CYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL24823440 0.80 TOP1 (0.53) CYP1A2CYP2D6CYP2C19CYP3A4MAPT
SCHEMBL23336404 0.79 P2RX1 (0.76) RXFP1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4432968 0.78 POLB (0.54) RXFP1CYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL5429717 0.78 POLB (0.54) RXFP1CYP1A2CYP2C19MAPTSMN1; SMN2
SCHEMBL28860522 0.78 ALDH1A1 (0.48) RXFP1CYP1A2CYP2D6CYP2C19CYP3A4
SCHEMBL30100391 0.77 TMPRSS4 (0.79) CYP1A2CYP2D6CYP2C19CYP3A4MAPT
SCHEMBL18341401 0.77 TMPRSS4 (0.79) CYP1A2CYP2D6CYP2C19CYP3A4MAPT
SCHEMBL15531106 0.77 RXFP1 (1.00) RXFP1
SCHEMBL21394911 0.76 TMPRSS4 (0.58) RXFP1CYP1A2CYP2D6CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019179436-A1 ACID AMIDE COMPOUND AND USE THEREOF IN TREATMENT OF CANCERS 成都海创药业有限公司 2019-09-26 WO disclosed